Raffles Medical Group(SG:BSL)
S$0.84+0.01 (+0.60%)
SG:BSL
Raffles Medical Group financials statements
S$0.84
At close:+0.01 (+0.60%)
Want to see SG:BSL full AI Analyst Report?
Raffles Medical Group (BSL) Ratios
98 Followers
Raffles Medical Group Ratios
SG:BSL's free cash flow for Q2 2026 was S$30.76M. For the 2026 fiscal year, SG:BSL's free cash flow was decreased by S$-1.52M and operating cash flow was S$32.28M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.31 | 1.35 | 1.28 | 1.36 | 1.05 |
| Quick Ratio | 1.27 | 1.32 | 1.24 | 1.33 | 1.02 |
| Cash Ratio | 0.93 | 0.90 | 0.91 | 0.70 | 0.64 |
| Solvency Ratio | 0.31 | 0.22 | 0.24 | 0.39 | 0.22 |
| Operating Cash Flow Ratio | 0.32 | 0.23 | 0.50 | 0.54 | 0.38 |
| Short-Term Operating Cash Flow Coverage | 2.13 | 12.56 | 10.67 | 20.30 | 1.66 |
| Net Current Asset Value | S$ 61.83M | S$ 50.51M | S$ 319.00K | S$ 27.05M | S$ -129.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.06 | 0.08 | 0.06 | 0.13 |
| Debt-to-Equity Ratio | 0.08 | 0.08 | 0.12 | 0.09 | 0.21 |
| Debt-to-Capital Ratio | 0.08 | 0.08 | 0.11 | 0.09 | 0.17 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.04 | 0.06 | 0.06 | 0.08 |
| Financial Leverage Ratio | 1.35 | 1.46 | 1.49 | 1.48 | 1.61 |
| Debt Service Coverage Ratio | 2.05 | 8.60 | 4.39 | 11.35 | 1.26 |
| Interest Coverage Ratio | 21.31 | 14.27 | 19.04 | 28.46 | 19.09 |
| Debt to Market Cap | 0.04 | 0.04 | 0.04 | 0.03 | 0.07 |
| Interest Debt Per Share | 0.05 | 0.05 | 0.07 | 0.06 | 0.11 |
| Net Debt to EBITDA | -1.69 | -1.92 | -1.65 | -0.67 | -0.41 |
| Profitability Margins | |||||
| Gross Profit Margin | 17.87% | 64.68% | 44.62% | 77.77% | 80.21% |
| EBIT Margin | 11.40% | 12.18% | 15.28% | 23.91% | 16.85% |
| EBITDA Margin | 17.23% | 17.75% | 18.77% | 28.66% | 22.28% |
| Operating Profit Margin | 11.40% | 10.98% | 16.35% | 23.80% | 16.76% |
| Pretax Profit Margin | 12.10% | 11.57% | 16.87% | 23.30% | 15.97% |
| Net Profit Margin | 9.22% | 8.28% | 12.73% | 17.40% | 11.63% |
| Continuous Operations Profit Margin | 9.29% | 8.29% | 12.87% | 17.43% | 11.57% |
| Net Income Per EBT | 76.19% | 71.57% | 75.48% | 74.71% | 72.82% |
| EBT Per EBIT | 106.14% | 105.42% | 103.18% | 97.89% | 95.28% |
| Return on Assets (ROA) | 4.94% | 4.07% | 5.90% | 9.56% | 5.45% |
| Return on Equity (ROE) | 6.67% | 5.93% | 8.77% | 14.11% | 8.76% |
| Return on Capital Employed (ROCE) | 7.96% | 7.18% | 10.08% | 17.26% | 10.75% |
| Return on Invested Capital (ROIC) | 5.79% | 5.07% | 7.50% | 12.36% | 7.11% |
| Return on Tangible Assets | 4.98% | 4.11% | 5.97% | 9.69% | 5.56% |
| Earnings Yield | 3.74% | 3.94% | 4.45% | 5.51% | 3.29% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.73 | 4.64 | 12.72 | 3.61 | 4.50 |
| Payables Turnover | 3.40 | 1.21 | 1.86 | 0.80 | 0.64 |
| Inventory Turnover | 55.81 | 24.66 | 31.46 | 9.66 | 10.71 |
| Fixed Asset Turnover | 1.03 | 1.00 | 0.92 | 1.11 | 0.91 |
| Asset Turnover | 0.54 | 0.49 | 0.46 | 0.55 | 0.47 |
| Working Capital Turnover Ratio | 6.47 | 6.27 | 5.98 | 10.70 | 19.64 |
| Cash Conversion Cycle | -46.42 | -207.03 | -155.84 | -314.51 | -451.20 |
| Days of Sales Outstanding | 54.25 | 78.62 | 28.69 | 101.18 | 81.06 |
| Days of Inventory Outstanding | 6.54 | 14.80 | 11.60 | 37.78 | 34.07 |
| Days of Payables Outstanding | 107.21 | 300.45 | 196.12 | 453.47 | 566.33 |
| Operating Cycle | 60.79 | 93.42 | 40.29 | 138.96 | 115.13 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.06 | 0.05 | 0.10 | 0.11 | 0.09 |
| Free Cash Flow Per Share | 0.05 | 0.04 | 0.09 | 0.09 | 0.06 |
| Dividend Paid and CapEx Coverage Ratio | 1.96 | 1.32 | 2.08 | 2.54 | 1.77 |
| Capital Expenditure Coverage Ratio | 13.47 | 4.13 | 9.22 | 7.76 | 3.03 |
| Operating Cash Flow Coverage Ratio | 1.21 | 0.98 | 1.52 | 2.04 | 0.81 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.11 | 0.27 | 0.24 | 0.22 |
| Free Cash Flow Yield | 5.20% | 4.14% | 8.33% | 6.57% | 4.19% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 26.77 | 25.37 | 22.48 | 18.16 | 30.40 |
| Price-to-Sales (P/S) Ratio | 2.47 | 2.10 | 2.86 | 3.16 | 3.53 |
| Price-to-Book (P/B) Ratio | 1.78 | 1.50 | 1.97 | 2.56 | 2.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 19.23 | 24.16 | 12.01 | 15.21 | 23.86 |
| Price-to-Operating Cash Flow Ratio | 17.81 | 18.30 | 10.71 | 13.25 | 15.98 |
| Price-to-Earnings Growth (PEG) Ratio | 1.95 | -0.82 | -0.60 | 0.25 | 1.17 |
| Enterprise Value Multiple | 12.62 | 9.92 | 13.60 | 10.36 | 15.45 |
| Enterprise Value | 1.66B | 1.32B | 1.81B | 2.44B | 2.49B |
| EV to EBITDA | 12.62 | 9.92 | 13.60 | 10.36 | 15.45 |
| EV to Sales | 2.17 | 1.76 | 2.55 | 2.97 | 3.44 |
| EV to Free Cash Flow | 16.96 | 20.25 | 10.71 | 14.29 | 23.23 |
| EV to Operating Cash Flow | 15.70 | 15.34 | 9.55 | 12.45 | 15.56 |
| Tangible Book Value Per Share | 0.56 | 0.57 | 0.55 | 0.54 | 0.51 |
| Shareholders’ Equity Per Share | 0.57 | 0.57 | 0.55 | 0.55 | 0.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.28 | 0.24 | 0.25 | 0.28 |
| Revenue Per Share | 0.41 | 0.40 | 0.38 | 0.44 | 0.39 |
| Net Income Per Share | 0.04 | 0.03 | 0.05 | 0.08 | 0.05 |
| Tax Burden | 0.76 | 0.72 | 0.75 | 0.75 | 0.73 |
| Interest Burden | 1.06 | 0.95 | 1.10 | 0.97 | 0.95 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.06 | 0.19 | 0.13 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.50 | 1.39 | 2.10 | 1.37 | 1.91 |
Currency in SGD

